百蕊胶囊辅助治疗小儿肺炎支原体肺炎的疗效分析

Analysis of the curative effect of Bairui capsule in the auxiliary treatment of Mycoplasma pneumoniae pneumonia in children

目的研究百蕊胶囊辅助治疗小儿肺炎支原体肺炎(MPP)的疗效。方法 156例肺炎支原体肺炎患儿,依据抽签方法分为参比组和研究组,每组78例。所有患儿均给予临床支持治疗及止咳、化痰、退热等对症治疗,参比组在此基础上给予静脉滴注阿奇霉素治疗,研究组在参比组的基础上给予口服百蕊胶囊辅助治疗。对比两组疗效及各项临床指标、不良反应发生情况。结果研究组治疗总有效率为91.03%,高于参比组的75.64%,差异有统计学意义(P<0.05)。研究组患儿咳嗽消失时间(5.26±2.13)d、退热时间(2.81±1.54)d、肺部体征消失时间(5.55±2.63)d、肺部X线恢复时间(6.02±1.54)d均显著短于参比组的(7.26±2.96)、(6.18±2.05)、(8.86±4.43)、(9.55±2.69)d,差异有统计学意义(P<0.05)。两组患儿不良反应发生率对比差异无统计学意义(P>0.05)。结论对于小儿肺炎支原体肺炎,采用百蕊胶囊进行辅助治疗,能快速消除患儿临床症状,提高治疗疗效,且引发的不良反应较少,安全性较高,值得推荐。

Objective To study the efficacy of Bairui granule in the auxiliary treatment of Mycoplasma pneumoniae pneumonia(MPP)in children.Methods A total of 156 children with Mycoplasma pneumoniae pneumonia were divided into reference group and research group according to lottery method,with 78 cases in each group.All children received clinical support treatment and symptomatic treatment such as cough relieving,phlegm resolving and fever reducing.The reference group received azithromycin intravenous drip on the basis of the reference group,and the research group received Bairui capsule adjuvant treatment on the basis of the reference group.The efficacy,clinical indicators and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment of the research group was 91.03%,which was higher than 75.64%of the reference group,and the difference was statistically significant(P<0.05).The cough disappearance time(5.26±2.13)d,fever reduction time(2.81±1.54)d,lung sign disappearance time(5.55±2.63)d,and lung X-ray recovery time(6.02±1.54)d of the research group were all shorter than(7.26±2.96),(6.18±2.05),(8.86±4.43),(9.55±2.69)d of the reference group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in incidence of adverse reactions between the two groups(P>0.05).Conclusion For children with Mycoplasma pneumoniae pneumonia,Bairui capsule for adjuvant treatment can quickly eliminate the clinical symptoms of the children,improve the therapeutic effect with fewer adverse reactions and high safety,and it is worth recommending.